CACLP - The largest IVD Expo & Conference

IVD China last week: Siemens Healthineers, Snibe, Fosun Diagnostics, Medconn Diagnostics

Industry news | 08 July, 2025 | CACLP

Siemens Healthineers Officially Launches First APAC Production Line for Laboratory Diagnostics Equipment

 

Siemens Healthineers' first domestically produced high-end laboratory diagnostics system—the Atellica automated biochemical and immunoassay analyzer—has officially commenced production at its Shanghai R&D and manufacturing base. This also marks the company's first laboratory diagnostics instrument production line in the Asia-Pacific region.

 

The locally manufactured product received NMPA approval in April this year. With this production launch, Siemens Healthineers has achieved full-range domestic manufacturing capabilities across major product lines, including large imaging diagnostics equipment, clinical interventional therapy devices, and laboratory diagnostics systems.

 

 

Snibe's Biochemistry Analysis System Receives CDC Certification

 

 

 

Recently, Shenzhen New Industries Biomedical's (SNIBE) Total Cholesterol (TC) assay obtained certification from the CDC-CRMLN (Cholesterol Reference Method Laboratory Network). This certification confirms that the assay meets the performance standards set by the U.S. National Cholesterol Education Program (NCEP) and is traceable to international reference methods, serving as strong validation of SNIBE's high-quality reagents.

 

 

Fosun Diagnostics and Siemens Healthineers Unveil First Joint Innovation to Foster Localized Collaborative Ecosystem

 

 

As Siemens Healthineers launched its first domestically produced high-end diagnostic system, the Atellica automated biochemical and immunoassay analyzer, Fosun Diagnostics officially announced a strategic partnership with the company to introduce their first collaborative product—a locally developed biochemical reagent solution. This collaboration marks a new phase in deepening localized innovation and enhancing the accessibility of high-end domestic diagnostic products between Chinese healthcare technology leaders and global giants. By integrating technology, production capacity, and global resources, the two parties will jointly drive innovation and advancement in the in vitro diagnostics (IVD) sector.

 

 

 

Medconn Diagnostics Secures First FDA Approval

 

 

 

Recently, the U.S. Food and Drug Administration (FDA) officially granted 510(k) clearance to Medconn Diagnostics' independently developed MQ-3000/MQ-3000PT Glycated Hemoglobin (HbA1c) Testing System. This marks the first FDA-registered HbA1c detection device from China based on High-Performance Liquid Chromatography (HPLC) technology, representing a historic breakthrough for domestically developed HPLC technology in the in vitro diagnostics (IVD) field.

Filed under:
Press contact CACLP - The largest IVD Expo & Conference

Stay in touch with CACLP News

We deliver the latest IVD news straight to your inbox. Stay in touch with CACLP News, sign-up for our newsletter today.

  • Name *
  • Email *
  • Company name *
  • Country *
    CACLP - The largest IVD Expo & Conference

By subscribing our newsletter, you agree to our Privacy Policy. You can unsubscribe at anytime.

Share
Opening Countdown
0 0 0

Day(s)

0 0

Hour(s)

0 0

Min(s)

Room 1808, Cloud Nine Plaza
1118 West Yan’an Road
Shanghai, China
200052

Copyright © 2025 GL events Ruihe (Shanghai) Exhibition Co., Ltd. All Rights Reserved. ( 沪ICP备12004745号-1 )

We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy & Cookies for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

CACLP - The largest IVD Expo & Conference